Riccardo Braglia

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Helsinn Healthcare Sa, Roche Palo Alto LLC, Helsinn Advanced Synthesis Sa. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riccardo Braglia. Retrieved from https://idiyas.com/inventor/riccardo-braglia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 47(Granted Patents)

Location History:

Biasca, CH (2006)
Pazzallo, CH (2011)
Lugano-Pazzallo, CH (2012)

Company Filing History:

4 out of 70

Helsinn Healthcare Sa

Helsinn Advanced Synthesis Sa

patent

where one patent can have more than one assignee

Years Active: 2006-2012

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. D665072 - Capsule for pharmaceutical products (2012-08-07),

2. 7960424 - Liquid pharmaceutical formulations of palonosetron (2011-06-14),

3. 7947725 - Liquid pharmaceutical formulations of palonosetron (2011-05-24),

4. 7947724 - Liquid pharmaceutical formulations of palonosetron (2011-05-24),

5. 7057058 - Process for the preparation of 13-cis-retinoic acid (2006-06-06),

Title: Riccardo Braglia: Innovator in Pharmaceutical Formulations

Introduction

Riccardo Braglia is a notable inventor based in Pazzallo, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 5 patents. His work focuses on developing innovative solutions to improve patient care and treatment efficacy.

Latest Patents

One of Riccardo Braglia's latest patents is a capsule designed for pharmaceutical products. This invention includes liquid pharmaceutical formulations of palonosetron, which are shelf-stable and aimed at reducing chemotherapy and radiotherapy-induced emesis. The formulations he developed are particularly useful in the preparation of intravenous and oral liquid medicaments, showcasing his commitment to enhancing therapeutic options for patients.

Career Highlights

Throughout his career, Riccardo has worked with prominent companies in the pharmaceutical industry, including Helsinn Healthcare SA and Roche Palo Alto LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in medication formulations.

Collaborations

Riccardo has collaborated with talented professionals in his field, including Daniele Bonadeo and Roberta Cannella. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Riccardo Braglia's contributions to pharmaceutical formulations demonstrate his dedication to improving healthcare solutions. His innovative patents and collaborations highlight his role as a key figure in the industry.

Profile summary based on public USPTO records.